BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 32864098)

  • 1. Interleukin-6 signalling in health and disease.
    Rose-John S
    F1000Res; 2020; 9():. PubMed ID: 32864098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6.
    Rose-John S
    Int J Biol Sci; 2012; 8(9):1237-47. PubMed ID: 23136552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
    Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissecting Interleukin-6 Classic- and Trans-Signaling in Inflammation and Cancer.
    Garbers C; Rose-John S
    Methods Mol Biol; 2018; 1725():127-140. PubMed ID: 29322414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The IL-6/sIL-6R complex as a novel target for therapeutic approaches.
    Rose-John S; Waetzig GH; Scheller J; Grötzinger J; Seegert D
    Expert Opin Ther Targets; 2007 May; 11(5):613-24. PubMed ID: 17465721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 trans-signalling in chronic inflammation and cancer.
    Scheller J; Ohnesorge N; Rose-John S
    Scand J Immunol; 2006 May; 63(5):321-9. PubMed ID: 16640655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 controls recycling and degradation, but not internalization of its receptors.
    Flynn CM; Kespohl B; Daunke T; Garbers Y; Düsterhöft S; Rose-John S; Haybaeck J; Lokau J; Aparicio-Siegmund S; Garbers C
    J Biol Chem; 2021; 296():100434. PubMed ID: 33610555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to IL-6 trans- and IL-6 classic signalling is determined by the ratio of the IL-6 receptor α to gp130 expression: fusing experimental insights and dynamic modelling.
    Reeh H; Rudolph N; Billing U; Christen H; Streif S; Bullinger E; Schliemann-Bullinger M; Findeisen R; Schaper F; Huber HJ; Dittrich A
    Cell Commun Signal; 2019 May; 17(1):46. PubMed ID: 31101051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer.
    Rose-John S; Scheller J; Elson G; Jones SA
    J Leukoc Biol; 2006 Aug; 80(2):227-36. PubMed ID: 16707558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The structure of the unliganded extracellular domain of the interleukin-6 signal transducer gp130 in solution.
    Lorenzen I; Shang W; Perbandt M; Petoukhov MV; Svergun DI; Waetzig GH; Rose-John S; Hilgenfeld R; Grötzinger J
    Eur J Cell Biol; 2011; 90(6-7):515-20. PubMed ID: 21035897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasticity and cross-talk of interleukin 6-type cytokines.
    Garbers C; Hermanns HM; Schaper F; Müller-Newen G; Grötzinger J; Rose-John S; Scheller J
    Cytokine Growth Factor Rev; 2012 Jun; 23(3):85-97. PubMed ID: 22595692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the interleukin (IL)-6/IL-6 receptor axis in cancer.
    Taher MY; Davies DM; Maher J
    Biochem Soc Trans; 2018 Dec; 46(6):1449-1462. PubMed ID: 30467123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 trans-signaling in inflammatory bowel disease.
    Mitsuyama K; Sata M; Rose-John S
    Cytokine Growth Factor Rev; 2006 Dec; 17(6):451-61. PubMed ID: 17045835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The soluble IL-6 receptors: serum levels and biological function.
    Montero-Julian FA
    Cell Mol Biol (Noisy-le-grand); 2001 Jun; 47(4):583-97. PubMed ID: 11502067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-6 receptor independent stimulation of human gp130 by viral IL-6.
    Müllberg J; Geib T; Jostock T; Hoischen SH; Vollmer P; Voltz N; Heinz D; Galle PR; Klouche M; Rose-John S
    J Immunol; 2000 May; 164(9):4672-7. PubMed ID: 10779772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Principles of interleukin (IL)-6-type cytokine signalling and its regulation.
    Heinrich PC; Behrmann I; Haan S; Hermanns HM; Müller-Newen G; Schaper F
    Biochem J; 2003 Aug; 374(Pt 1):1-20. PubMed ID: 12773095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
    Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC
    J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
    Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G
    J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of IL-6 trans-signaling in CCl₄induced liver damage.
    Gewiese-Rabsch J; Drucker C; Malchow S; Scheller J; Rose-John S
    Biochim Biophys Acta; 2010 Nov; 1802(11):1054-61. PubMed ID: 20691261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 and its receptors: a highly regulated and dynamic system.
    Wolf J; Rose-John S; Garbers C
    Cytokine; 2014 Nov; 70(1):11-20. PubMed ID: 24986424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.